KEGG   NETWORK: N00232
Entry
N00232                      Network                                
Name
TGFA-overexpression to PI3K signaling pathway
Definition
TGFA* -> EGFR -> PI3K -> PIP3 -> AKT
  Expanded
7039v1 -> 1956 -> (5290,5291,5293) -> C05981 -> (207,208,10000)
Class
nt06260 Colorectal cancer
nt06263 Hepatocellular carcinoma
nt06214 PI3K signaling (cancer)
Type
Variant
Pathway
hsa05210  Colorectal cancer
hsa05225  Hepatocellular carcinoma
Disease
H00020  Colorectal cancer
H00048  Hepatocellular carcinoma
Gene
7039  TGFA; transforming growth factor alpha
1956  EGFR; epidermal growth factor receptor
5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
207  AKT1; AKT serine/threonine kinase 1
208  AKT2; AKT serine/threonine kinase 2
10000  AKT3; AKT serine/threonine kinase 3
Variant
7039v1 (TGFA*)  TGFA overexpression
Metabolite
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Yarden Y, Sliwkowski MX.
  Title
Untangling the ErbB signalling network.
  Journal
Nat Rev Mol Cell Biol 2:127-37 (2001)
DOI:10.1038/35052073
Reference
  Authors
Hutchinson RA, Adams RA, McArt DG, Salto-Tellez M, Jasani B, Hamilton PW
  Title
Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer.
  Journal
J Transl Med 13:217 (2015)
DOI:10.1186/s12967-015-0531-z
Reference
  Authors
Whittaker S, Marais R, Zhu AX
  Title
The role of signaling pathways in the development and treatment of hepatocellular carcinoma.
  Journal
Oncogene 29:4989-5005 (2010)
DOI:10.1038/onc.2010.236
Reference
  Authors
Villanueva A, Newell P, Chiang DY, Friedman SL, Llovet JM.
  Title
Genomics and signaling pathways in hepatocellular carcinoma.
  Journal
Semin Liver Dis 27:55-76 (2007)
DOI:10.1055/s-2006-960171

DBGET integrated database retrieval system